11068 Federal Register / Vol. 87, No. 39 / Monday, February 28, 2022 / Notices 

Changes in the Estimates: There is an 

adjustment decrease in the total 

estimated burden as currently identified 

in the OMB Inventory of Approved 

Burdens. This decrease is not due to any 

program changes. The adjustment 

decrease in burden from the most 

recently-approved ICR is due to a 

decrease in the number of sources. 

Consultations with the Agency’s 

internal industry experts have shown 

that a number of cell chlor-alkali plants 

have shut down since the previous ICR 

renewal, leading to a decrease in 

respondent labor hours and the number 

of responses. There are no capital or 

operation and maintenance costs 

associated with this ICR. The overall 

result is a decrease in burden. 

Courtney Kerwin, 

Director, Regulatory Support Division. 

[FR Doc. 2022–04133 Filed 2–25–22; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OW–2014–0359; FRL–9615–01– 

OMS] 

Information Collection Request 

Submitted to OMB for Review and 

Approval; Comment Request; 

Underground Injection Control 

Program (Renewal) 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Environmental Protection 

Agency has submitted an information 

collection request (ICR), Underground 

Injection Control (UIC) Program (EPA 

ICR Number 0370.27, OMB Control 

Number 2040–0042) to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act (PRA). 

This is a proposed extension of the ICR, 

which is currently approved through 

April 30, 2022. Public comments were 

previously requested via the Federal 

Register on August 25, 2021, during a 

60-day comment period. This notice 

allows for an additional 30 days for 

public comments. A fuller description 

of the ICR is given below, including its 

estimated burden and cost to the public. 

An agency may not conduct or sponsor 

and a person is not required to respond 

to a collection of information unless it 

displays a currently valid OMB control 

number. 

DATES: Additional comments may be 

submitted on or before March 30, 2022. 

ADDRESSES: Submit your comments, 

referencing Docket ID Number EPA– 

HQ–OW–2014–0359, to EPA online 

using https://www.regulations.gov (our 

preferred method), by email to OWDocket@epa.gov, or by mail to: EPA 

Docket Center, Environmental 

Protection Agency, Mail Code 28221T, 

1200 Pennsylvania Ave. NW, 

Washington, DC 20460. 

EPA’s policy is that all comments 

received will be included in the public 

docket without change including any 

personal information provided, unless 

the comment includes profanity, threats, 

information claimed to be confidential 

business information or other 

information whose disclosure is 

restricted by statute. 

Submit written comments and 

recommendations to OMB for the 

proposed information collection within 

30 days of publication of this notice to 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function. 

FOR FURTHER INFORMATION CONTACT: Kyle 

Carey, Drinking Water Protection 

Division, Office of Ground Water and 

Drinking Water, 4606M, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW, Washington, DC 20460; 

telephone number: (202) 564–2322; fax 

number: (202) 564–3756; email address: 

carey.kyle@epa.gov. 

SUPPLEMENTARY INFORMATION: 

Supporting documents, which explain 

in detail the information that the EPA 

will be collecting, are available in the 

public docket for this ICR. The docket 

can be viewed online at https://

www.regulations.gov or in person at the 

EPA Docket Center, WJC West, Room 

3334, 1301 Constitution Ave. NW, 

Washington, DC 20004. The telephone 

number for the Docket Center is 202– 

566–1744. For additional information 

about EPA’s public docket, visit http:// 

www.epa.gov/dockets. 

Abstract: EPA developed the 

Underground Injection Control (UIC) 

Program under the authority of the Safe 

Drinking Water Act to establish a 

federal-state regulatory system to protect 

underground sources of drinking water 

(USDWs) from injection fluids and 

injection-related activities. These rules 

are designed to ensure that Americans 

receive safe drinking water, and ensure 

fair treatment and meaningful 

involvement of all people regardless of 

race, color, national origin, or income. 

Injected fluids include hazardous waste, 

oil field brines or produced water, 

mineral processing fluids, various types 

of industrial fluids, automotive, 

sanitary, and other wastes, and carbon 

dioxide injected for geologic 

sequestration. Owners or operators of 

injection wells must obtain permits, 

conduct environmental monitoring, 

maintain records, and report results to 

EPA or the state agency (if the state has 

UIC primary enforcement responsibility 

(primacy)). States must report to EPA on 

permittee compliance and related 

information. This mandatory 

information is reported using 

standardized forms and annual reports. 

Reporting data are used by UIC 

authorities to ensure the protection of 

USDWs. 

Form Numbers: 7520–1, 7520–2A, 

7520–2B, 7520–3, 7520–4, 7520–6, 

7520–7, 7520–8, 7520–11, 7520–16, 

7520–17, 7520–18, and 7520–19. 

Respondents/affected entities: 

Owners or operators of underground 

injection wells and State UIC primacy 

agencies. 

Respondent’s obligation to respond: 

Mandatory (40 CFR parts 144 through 

148). 

Estimated number of respondents: 

37,677 (total). 

Frequency of response: Annual, semiannual, quarterly. 

Total estimated burden: 1,631,360 

hours (per year). Burden is defined at 5 

CFR 1320.03(b). 

Total estimated cost: $363,309,464 

(per year), includes $276,069,465 

annualized capital or operation and 

maintenance costs. 

Changes in the estimates: There is an 

increase of 339,100 hours in the total 

estimated respondent burden compared 

with the ICR currently approved by 

OMB. This increase is due to 

adjustments that include an increase in 

the number of Class I, Class II, Class III, 

and Class VI permit applications 

expected to be prepared and reviewed 

by UIC permitting authorities during the 

upcoming ICR period. The overall 

increase is partially offset by an 

inventory adjustment that results in a 

decrease in the number of current 

operators that will perform monitoring, 

reporting, and recordkeeping activities 

over the life of an injection project (due 

to decreases in the injection well 

inventory). Programmatic changes that 

result in minor changes to the burden 

estimate include revisions to the 

reporting forms and changes in 

reporting of primacy state program 

information, including implementing 

electronic reporting options (which will 

reduce the burden to primacy agencies) 

and anticipated approval of Class VI 

UIC Program primacy for several states, 

which will increase state burden (by 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 39 / Monday, February 28, 2022 / Notices 11069 

shifting burden from EPA to the 

approved states). 

Courtney Kerwin, 

Director, Regulatory Support Division. 

[FR Doc. 2022–04106 Filed 2–25–22; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2022–0132; FRL–9411–01– 

OCSPP] 

Certain New Chemicals; Receipt and 

Status Information for January 2022 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: EPA is required under the 

Toxic Substances Control Act (TSCA) to 

make certain information publicly 

available and to publish information in 

the Federal Register pertaining to 

submissions, including notice of receipt 

of a Premanufacture notice (PMN), 

Significant New Use Notice (SNUN) or 

Microbial Commercial Activity Notice 

(MCAN), including an amended notice 

or test information; an exemption 

application (Biotech exemption); an 

application for a test marketing 

exemption (TME), both pending and/or 

concluded; a notice of commencement 

(NOC) of manufacture (including 

import) for new chemical substances; 

and a periodic status report on new 

chemical substances that are currently 

under EPA review or have recently 

concluded review. This document 

covers the period from 01/01/2022 to 

01/31/2022. 

DATES: Comments identified by the 

specific case number provided in this 

document must be received on or before 

March 30, 2022. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2022–0132, 

and the specific case number for the 

chemical substance related to your 

comment, through the Federal 

eRulemaking Portal at https://

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. Additional 

instructions on commenting or visiting 

the docket, along with more information 

about dockets generally, is available at 

https://www.epa.gov/dockets. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

closed to visitors with limited 

exceptions. The staff continues to 

provide remote customer service via 

email, phone, and webform. For the 

latest status information on EPA/DC 

services and docket access, visit https:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT:

For technical information contact: Jim 

Rahai, Project Management and 

Operations Division (7407M), Office of 

Pollution Prevention and Toxics, 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW, Washington, DC 

20460–0001; telephone number: (202) 

564–8593; email address: rahai.jim@

epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. Executive Summary 

A. What action is the Agency taking? 

This document provides the receipt 

and status reports for the period from 

01/01/2022 to 01/31/2022. The Agency 

is providing notice of receipt of PMNs, 

SNUNs, and MCANs (including 

amended notices and test information); 

an exemption application under 40 CFR 

part 725 (Biotech exemption); TMEs, 

both pending and/or concluded; NOCs 

to manufacture a new chemical 

substance; and a periodic status report 

on new chemical substances that are 

currently under EPA review or have 

recently concluded review. 

EPA is also providing information on 

its website about cases reviewed under 

the amended TSCA, including the 

section 5 PMN/SNUN/MCAN and 

exemption notices received, the date of 

receipt, the final EPA determination on 

the notice, and the effective date of 

EPA’s determination for PMN/SNUN/ 

MCAN notices on its website at: https:// 

www.epa.gov/reviewing-new-chemicalsunder-toxic-substances-control-act-tsca/ 

status-pre-manufacture-notices. This 

information is updated on a weekly 

basis. 

B. What is the Agency’s authority for 

taking this action? 

Under TSCA, 15 U.S.C. 2601 et seq., 

a chemical substance may be either an 

‘‘existing’’ chemical substance or a 

‘‘new’’ chemical substance. Any 

chemical substance that is not on EPA’s 

TSCA Inventory of Chemical Substances 

(TSCA Inventory) is classified as a ‘‘new 

chemical substance,’’ while a chemical 

substance that is listed on the TSCA 

Inventory is classified as an ‘‘existing 

chemical substance.’’ (See TSCA section 

3(11).) For more information about the 

TSCA Inventory please go to: https://

www.epa.gov/tsca-inventory. 

Any person who intends to 

manufacture (including import) a new 

chemical substance for a non-exempt 

commercial purpose, or to manufacture 

or process a chemical substance in a 

non-exempt manner for a use that EPA 

has determined is a significant new use, 

is required by TSCA section 5 to 

provide EPA with a PMN, MCAN, or 

SNUN, as appropriate, before initiating 

the activity. EPA will review the notice, 

make a risk determination on the 

chemical substance or significant new 

use, and take appropriate action as 

described in TSCA section 5(a)(3). 

TSCA section 5(h)(1) authorizes EPA 

to allow persons, upon application and 

under appropriate restrictions, to 

manufacture or process a new chemical 

substance, or a chemical substance 

subject to a significant new use rule 

(SNUR) issued under TSCA section 

5(a)(2), for ‘‘test marketing’’ purposes, 

upon a showing that the manufacture, 

processing, distribution in commerce, 

use, and disposal of the chemical will 

not present an unreasonable risk of 

injury to health or the environment. 

This is referred to as a test marketing 

exemption, or TME. For more 

information about the requirements 

applicable to a new chemical go to: 

https://www.epa.gov/oppt/newchems. 

Under TSCA sections 5 and 8 and 

EPA regulations, EPA is required to 

publish in the Federal Register certain 

information, including notice of receipt 

of a PMN/SNUN/MCAN (including 

amended notices and test information); 

an exemption application under 40 CFR 

part 725 (biotech exemption); an 

application for a TME, both pending 

and concluded; NOCs to manufacture a 

new chemical substance; and a periodic 

status report on the new chemical 

substances that are currently under EPA 

review or have recently concluded 

review. 

C. Does this action apply to me? 

This action provides information that 

is directed to the public in general. 

D. Does this action have any 

incremental economic impacts or 

paperwork burdens? 

No. 

E. What should I consider as I prepare 

my comments for EPA? 

1. Submitting confidential business 

information (CBI). Do not submit this 

information to EPA through 

regulations.gov or email. Clearly mark 

the part or all of the information that 


khammond on DSKJM1Z7X2PROD with NOTICES